Archived David Kirn Scientific Publications – 2008

Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic livercancer: a phase I trial.

Park BH, Hwang T, Liu TC, Sze DY, Kim JS, Kwon HC, Oh SY, Han SY, Yoon JH, Hong SH, Moon A, Speth K, Park C, Ahn YJ, Daneshmand M, Rhee BG, Pinedo HM, Bell JC, Kirn DH. Lancet Oncol. ...

MicroRNAs fine-tune oncolytic viruses.

Bell JC, Kirn D. Nature Biotechnology. 2008 Dec;26(12):1346-8....